Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Latest filing published 23 Apr 2026 for Structure Therapeutics Inc.. Read the official filing
Filing timeline
BuySaleMatthew Lang
Insider track record
Disclosed buys
0
Disclosed sells
11
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Matthew Lang: trading record in brief
Filings by Matthew Lang span 4 companies, the busiest being Myovant Sciences Ltd., Lyell Immunopharma, Inc. and Metsera, Inc. The record holds 18 filings, for trades running from 9 July 2021 to 15 April 2026.
No open-market purchase appears, only 11 sales worth €738k. Other entries cover 5 share grants.
Most recently, on 23 April 2026, the filings show a share grant in Structure Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Matthew Lang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
184,614 shares0Ordinary SharesSEC:0001712069-26-000007:0
12,500 sharesCommon StockSEC:0001193125-25-280812:0
112,500 shares0Common StockSEC:0001415889-25-005775:0
50,000 shares0Common StockSEC:0001209191-24-003276:0
113,145 sharesCommon SharesSEC:0001209191-23-017719:0
1,272 shares@ US$26.893.0% of flowCommon SharesSEC:0001209191-23-004285:0
2,779 shares@ US$26.906.7% of flowCommon SharesSEC:0001209191-23-001951:0
1,933 shares@ US$25.204.7% of flowCommon SharesSEC:0001209191-22-054195:0
3,679 shares@ US$24.408.5% of flowCommon SharesSEC:0001209191-22-052984:0
124,780 shares0Common SharesSEC:0001209191-22-046001:0
1,935 shares@ US$12.872.3% of flowCommon SharesSEC:0001209191-22-042694:0
3,702 shares@ US$13.404.6% of flowCommon SharesSEC:0001209191-22-041615:0
8,002 shares@ US$10.4510.5% of flowCommon SharesSEC:0001209191-22-025174:0
111,111 shares0Common SharesSEC:0001209191-22-024786:0
2,436 shares@ US$13.784.2% of flowCommon SharesSEC:0001209191-22-023666:0
4,475 shares@ US$16.278.7% of flowCommon SharesSEC:0001209191-22-002202:0
6,671 shares@ US$21.6216.8% of flowCommon SharesSEC:0001209191-21-059910:0
6,954 shares@ US$21.5217.1% of flowCommon SharesSEC:0001209191-21-046492:0
18 of 18 declarations
